NorthWest Biotherapeutics Inc (NWBO)

[rogers5729]

Well, genuine question: at what point is methylation status tested (and how). Just positing that maybe the fact that non-crossovers are likely to die suddenly or to break off clinical visits for the trial altogether (that is, decide not to crossover), that that is a contributor to poor characterization of meth status. Again, I’m unfamiliar with how that characterization is done, so this could be off base.